2,3-dimethylmaleic anhydride has been researched along with Extravascular Hemolysis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dai, HB; Luo, L; Maruf, A; Nurhidayah, D; Sun, D; Wang, GX; Wang, JX; Wang, Y; Wu, W; Zhang, XJ; Zhong, Y | 1 |
Bao, W; Li, D; Li, F; Li, Y; Liu, B; Liu, X; Lu, GH; Lv, Y; Wei, W; Zhang, F | 1 |
2 other study(ies) available for 2,3-dimethylmaleic anhydride and Extravascular Hemolysis
Article | Year |
---|---|
Acid-Activated Melittin for Targeted and Safe Antitumor Therapy.
Topics: Acids; Animals; Antineoplastic Agents; Biocompatible Materials; Cell Survival; Chromatography, High Pressure Liquid; Drug Delivery Systems; HeLa Cells; Hemolysis; Humans; Hydrogen-Ion Concentration; Larva; Maleic Anhydrides; Melitten; Neoplasms; Proton Magnetic Resonance Spectroscopy; Reproducibility of Results; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Zebrafish | 2018 |
Nanolongan with Multiple On-Demand Conversions for Ferroptosis-Apoptosis Combined Anticancer Therapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Doxorubicin; Drug Carriers; Drug Liberation; Ferroptosis; Hemolysis; Infrared Rays; Iron; Lysosomes; Maleic Anhydrides; Metal Nanoparticles; Mice; Oxidation-Reduction; Rabbits; Starch; Ultraviolet Rays | 2019 |